Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Prepaid Assets (2022 - 2025)

Entrada Therapeutics has reported Prepaid Assets over the past 4 years, most recently at $8.7 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $8.7 million for Q4 2025, down 46.71% from a year ago — trailing twelve months through Dec 2025 was $8.7 million (down 46.71% YoY), and the annual figure for FY2025 was $8.7 million, down 46.71%.
  • Prepaid Assets for Q4 2025 was $8.7 million at Entrada Therapeutics, down from $10.2 million in the prior quarter.
  • Over the last five years, Prepaid Assets for TRDA hit a ceiling of $24.4 million in Q3 2023 and a floor of $8.7 million in Q4 2025.
  • Median Prepaid Assets over the past 4 years was $12.8 million (2024), compared with a mean of $14.0 million.
  • Peak annual rise in Prepaid Assets hit 101.58% in 2025, while the deepest fall reached 46.71% in 2025.
  • Entrada Therapeutics' Prepaid Assets stood at $21.2 million in 2022, then crashed by 43.66% to $11.9 million in 2023, then surged by 37.21% to $16.4 million in 2024, then crashed by 46.71% to $8.7 million in 2025.
  • The last three reported values for Prepaid Assets were $8.7 million (Q4 2025), $10.2 million (Q3 2025), and $14.0 million (Q2 2025) per Business Quant data.